Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of oncology and ...

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced its participation in the Jefferies Global ...

For decades, families have been told there was no cure for Duchenne Muscular Dystrophy, or DMD, a rare genetic condition that causes muscles to weaken over time, and few treatment options. But today, ...

Learn more Dyne Therapeutics DYN announced the submission of a biologics license application (BLA) to the FDA seeking ...

Reviewer Select has launched its new website, giving publishers, journal editors, and editorial teams a clearer view of its ...

ReviewerOne will present an industry breakout session at the 48th Annual Meeting of the Society for Scholarly Publishing (SSP ...

While Exxon Mobil isn't leaving Delaware, the company's redomiciliation proposal furthers a nationwide conversation around ...